About this product
AOD 3ml Pen is supplied at 5mg/3ml. [Per-product description to be added.]
What It Does
Six Reasons Clinicians Recommend AOD-9604
A synthetic 16-amino acid peptide engineered from the lipolytic C-terminal fragment of human growth hormone — the specific region of HGH responsible for fat metabolism. AOD-9604 delivers growth hormone's fat-burning signal with precision, without affecting blood sugar, insulin sensitivity, muscle tissue, or IGF-1 levels.
Full HGH
Stimulates fat metabolism but also raises IGF-1, affects blood glucose, promotes tissue growth, and carries risks of insulin resistance, acromegaly, and cardiomegaly with prolonged use. A blunt instrument — everything HGH does comes packaged together.
AOD-9604
Engineered from HGH's fat-metabolizing fragment only. Delivers lipolytic signaling without raising IGF-1, without affecting blood sugar or insulin sensitivity, and without stimulating tissue growth. Precision fat loss — nothing else.
Targeted Fat Loss Without Systemic HGH Effects
AOD-9604 activates the same beta-3 adrenergic receptor pathway that growth hormone uses to stimulate lipolysis — triggering the breakdown of stored triglycerides in adipose tissue for use as energy. Because it is derived from HGH's C-terminal fragment only, it produces this fat-burning signal without engaging the receptor domains responsible for IGF-1 elevation, tissue growth, or glucose metabolism changes. The result is targeted fat metabolism that doesn't carry the endocrine trade-offs of full HGH administration.
Targets Stubborn Fat Deposits
AOD-9604 demonstrates preferential activity in stubborn fat depots — the visceral, subcutaneous abdominal, and other hormonally-driven fat areas that resist diet and exercise most persistently. By directly activating the lipolytic signaling pathway in these fat cells, it mobilizes stored fat for oxidation in regions where beta-adrenergic receptor density is high but natural stimulation is low — addressing the biological asymmetry that makes certain fat deposits so resistant to conventional fat loss approaches.
No Effect on Blood Sugar or Insulin
One of AOD-9604's most clinically important properties is its metabolic neutrality — it does not affect fasting glucose, post-meal glucose, insulin secretion, or insulin sensitivity. This makes it uniquely appropriate for individuals with pre-diabetes, metabolic syndrome, or insulin resistance where full HGH or other fat loss agents that affect glucose metabolism are contraindicated. Patients can pursue fat loss without the blood sugar management concerns that accompany most pharmacological weight loss interventions.
Preserves Lean Muscle Mass
Because AOD-9604 does not elevate IGF-1 or affect anabolic signaling pathways, it produces fat loss without the muscle-preserving anabolic effects of full HGH — making it a purely catabolic-in-fat, neutral-in-muscle compound. Unlike GLP-1 agents that cause significant muscle loss alongside fat reduction, AOD-9604's mechanism is specific to adipose tissue metabolism and leaves lean tissue composition unchanged. This makes it appropriate for individuals who want fat loss without disturbing their current muscle mass or training adaptations.
Supports Cartilage & Joint Health
Beyond its fat-metabolizing primary indication, AOD-9604 has demonstrated cartilage-protective and regenerative properties in research settings — supporting chondrocyte activity and proteoglycan synthesis in joint tissue. These findings are consistent with the known role of the HGH C-terminal domain in connective tissue health. For individuals pursuing fat loss alongside joint health improvement — a common clinical presentation in overweight patients with osteoarthritis — AOD-9604 offers a meaningful secondary benefit beyond body composition.
FDA GRAS Status — Strong Safety Profile
AOD-9604 was granted Generally Recognized As Safe (GRAS) status by the FDA — an important regulatory designation reflecting its established human safety profile from extensive clinical evaluation. While not approved as a drug, its GRAS status distinguishes it from most research peptides and reflects the substantial human safety data accumulated during its development as an anti-obesity pharmaceutical. This safety track record makes AOD-9604 one of the most confidently administered fat loss peptides available through physician-supervised compounding protocols.
Commonly Stacked With CJC-1295 + Ipamorelin
AOD-9604 is frequently combined with CJC-1295 and Ipamorelin in body composition protocols. The GH secretagogue stack raises systemic GH and IGF-1 for anabolic and anti-aging effects — while AOD-9604 adds targeted lipolytic activity in adipose tissue. The combination allows patients to simultaneously pursue lean muscle support through elevated GH and IGF-1, and direct fat reduction through AOD-9604's adipose-specific mechanism — producing a more complete body composition protocol than either approach alone.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Available with a valid physician consultation only.
Formulated by Dr. Sasson Moulavi
Every Lavi MD peptide is developed under the direction of Dr. Sasson Moulavi, the physician behind the brand. Formulations are built to clinical specification, not sourced from anonymous suppliers.
Dr. Moulavi earned his Doctor of Medicine from the University of Toronto and completed postgraduate training at McGill University in Montreal. He holds Board Certification in Anti-Aging Medicine and Bariatric Medicine, and is a member of the American Academy of Anti-Aging Medicine and the American Society of Bariatric Physicians. With over three decades of clinical experience in bariatric, family, and anti-aging medicine, he serves as Medical Director and prescribing physician for Lavi MD, overseeing formulation standards and clinical protocols.
Simple, invoice-based ordering
No card is charged on this site. You build a request, we confirm it, and you pay a proper invoice. Built for how clinics and pharmacies actually buy.
Browse & build
Add products to your order request at wholesale pricing. No payment required.
Submit request
Send your request to our team. We review availability and confirm your order.
Get invoiced
You receive a QuickBooks invoice for the confirmed order and pay securely there.
Cold-chain ship
Once paid, your order is fulfilled and shipped cold-chain by our team.
Why Lavi MD
Not All Peptide Brands Are Equal
Most peptide suppliers prioritize volume over patients. We were built differently — by a physician, for patients.
Brands / Suppliers
Medical Director on Staff
Sasson Moulavi, MD
Dispensing Physician · Chayim Therapeutics, LLC
West Palm Beach, FL
"Every product we offer is something I would prescribe to my own patients. Our formulations are designed for clinical outcomes — not marketing claims."
How We Operate
Built by a Physician, Not a Marketing Team
Lavi MD was founded under physician supervision. Every formulation, every dose, every protocol is reviewed by Dr. Moulavi before it reaches a patient — not outsourced to a contract manufacturer with no clinical input.
We Limit Shipping Days to Protect Your Product
We only ship Monday and Tuesday. That's a deliberate decision — it ensures your order arrives before the weekend and never sits in a carrier facility over two days without refrigeration. Most brands don't think that far ahead.
We Treat You Like a Patient, Not an Order Number
Our team includes clinical staff who understand what you're taking and why. If something goes wrong with your order — a warm shipment, a missing component, a question about your protocol — we fix it. No automated runaround.
Proud Members of the
American Peptide Association
The American Peptide Association is the leading industry body advancing the science, safety, and standards of peptide research. Our membership reflects our unwavering commitment to purity, transparency, and responsible sourcing — giving you full confidence in every product you purchase.
